Denmark: Adcendo appoints Michael Pehl as CEO as company reaches inflection point

Michael Pehl has been appointed CEO of Adcendo, a Copenhagen-based biotech company dedicated to developing antibody-drug conjugates (ADCs) for the treatment of cancer. Henrik Stage, co-founder of Adcendo, will move to the role of CFO. Pehl has over 25 years of international biotechnology and oncology experience in both the US and Europe. He joins Adcendo…